Pascal Biosciences Inc (PAS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Pascal Biosciences Inc (PAS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8287
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pascal Biosciences Inc (Pascal Biosciences), formerly BioMmune Technologies Inc is a biotechnology company that discovers and develops treatments in the field of immuno-oncology. The company develops targeted agents that enable the body’s own immune system to recognize and attack cancers, infections and autoimmune diseases. It advances research programs such as developing a therapeutic monoclonal antibody for treatment of b-cell precursor acute lymphoblastic leukemia; optimizing novel classes of molecules that restore immune recognition and killing of cancer cells; and regulating activity of immune system calcium channels to combat cancers, infections, and autoimmune diseases. The company also conducts research on calcium channel blockers that modulates voltage-gated calcium channels for the signalling of immune system response and prevents transplant rejection. Pascal Biosciences is headquartered in Vancouver, British Columbia, Canada.

Pascal Biosciences Inc (PAS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pascal Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Biommune Enters into Agreement with University of British Columbia 10
Licensing Agreements 11
Pascal Biosciences Enters into Licensing Option Agreement with STC.UNM 11
Equity Offering 12
Pascal Biosciences Increases Size of Private Placement of Units for USD4 Million 12
Pascal Biosciences to Raise up to USD0.1 Million in Private Placement of Units 13
BioMmune Technologies Raises USD0.4 Million in Private Placement of Units 14
BioMmune Raise USD0.8 Million in Private Placement of Units 15
Acquisition 16
MC Partners Acquires bioMmune Advanced Technologies in Reverse Takeover Transaction 16
Pascal Biosciences Inc – Key Competitors 17
Pascal Biosciences Inc – Key Employees 18
Pascal Biosciences Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Strategy And Business Planning 20
May 09, 2017: Pascal Biosciences Creates Development Science Lab in Seattle WA 20
Corporate Communications 21
Jul 16, 2018: Pascal Biosciences names Julie M. Eastland as board director 21
Dec 05, 2017: Pascal Announces the Appointment of a New Director, Dr. Graeme I. Bell 22
Legal and Regulatory 23
Jun 18, 2018: Pascal Biosciences Receives DEA Schedule I License for Cannabinoid Development and Renews UBC Collaboration 23
Product News 24
Feb 21, 2018: Pascal Biosciences Identifies Molecules in Cannabis That Stimulate the Immune System to Destroy Tumor Cells 24
Other Significant Developments 25
Mar 30, 2017: bioMmune Announces Name Change to Pascal Biosciences 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pascal Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pascal Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Biommune Enters into Agreement with University of British Columbia 10
Pascal Biosciences Enters into Licensing Option Agreement with STC.UNM 11
Pascal Biosciences Increases Size of Private Placement of Units for USD4 Million 12
Pascal Biosciences to Raise up to USD0.1 Million in Private Placement of Units 13
BioMmune Technologies Raises USD0.4 Million in Private Placement of Units 14
BioMmune Raise USD0.8 Million in Private Placement of Units 15
MC Partners Acquires bioMmune Advanced Technologies in Reverse Takeover Transaction 16
Pascal Biosciences Inc, Key Competitors 17
Pascal Biosciences Inc, Key Employees 18

List of Figures
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Pascal Biosciences Inc (PAS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aspyrian Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aspyrian Therapeutics Inc (Aspyrian Therapeutics) is a clinical stage biotechnology company that develops first-in-class precision targeted cancer drugs for the treatment of solid tumors. The company harnesses the Photoimmunotherapy (PIT) platform to develop its products. Its lead pipeline p …
  • Mediaset S.p.A.:企業の戦略・SWOT・財務情報
    Mediaset S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Mediaset S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • BrainCool AB (BRAIN):企業の製品パイプライン分析2018
    Summary BrainCool AB (BrainCool), a subsidiary of Dignitana AB, is a medical device company that focuses on developing, and commercializing medical cooling systems for brain cooling and pain management. The company’s products are based on the principle that applying therapeutic hypothermia contribut …
  • The Real Good Food Company plc:企業の戦略・SWOT・財務分析
    The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report Summary The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • China National Petroleum Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary China National Petroleum Corp (CNPC) is an integrated energy company. Its businesses cover oil and gas exploration and development, refining and chemicals, marketing and trading, pipeline transmission and stockpiling, technical services, engineering construction, equipment manufacturing, fin …
  • Allscripts Healthcare Solutions Inc (MDRX)-医療機器分野:企業M&A・提携分析
    Summary Allscripts Healthcare Solutions Inc (Allscripts), formerly Allscripts-Misys Healthcare Solutions, Inc., is a provider of healthcare information technology solutions. The company’s major solutions include Electronic Health Records (EHR), Financial Management solutions, Population Health Manag …
  • Namibia Power Corporation (Proprietary) Ltd:企業の戦略的SWOT分析
    Namibia Power Corporation (Proprietary) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Scotiabank Private Banking:企業の戦略・SWOT・財務情報
    Scotiabank Private Banking - Strategy, SWOT and Corporate Finance Report Summary Scotiabank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Marafiq:発電所・企業SWOT分析
    Marafiq - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives …
  • Hetero Drugs Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Hetero Drugs Ltd (Hetero) is a manufacturer of active pharmaceutical ingredients, intermediate chemicals and finished dosages. The company specializes in process chemistry, API manufacturing, formulation development, manufacturing and commercialization of bio-generics, and also offers custom …
  • HeartSine Technologies LLC:企業の戦略的SWOT分析
    HeartSine Technologies LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Zen Technologies Limited:企業の戦略・SWOT・財務分析
    Zen Technologies Limited - Strategy, SWOT and Corporate Finance Report Summary Zen Technologies Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Vitro, S.A.B. de C.V.:企業の戦略・SWOT・財務情報
    Vitro, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Vitro, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • B. Braun Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary B. Braun Medical Inc (B. Braun), a subsidiary of B. Braun Melsungen AG, is a medical device company that provides infusion therapy and pain management technology, products and services. The company’s product portfolio includes TPN compounding bags, parenteral nutrition additives, closed syst …
  • Straco Corporation Limited:企業の戦略・SWOT・財務情報
    Straco Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Straco Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Enstar Group Ltd.:企業のM&A・事業提携・投資動向
    Enstar Group Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Enstar Group Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Glanbia Nutritionals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Glanbia Nutritionals Inc (Glanbia Nutritionals), a subsidiary of Glanbia plc is a provider of nutritional ingredients, functional ingredients, and customized premix solutions. The company manufactures and markets customized micronutrient blends, vitamins, minerals, amino acids, colors and sp …
  • Torax Medical Inc-医療機器分野:企業M&A・提携分析
    Summary TORAX Medical Inc (Torax Medical), a subsidiary of Ethicon US LLC, is a healthcare company that offers technology solutions. The company provides LINX reflux management system, a clinical stage medical device. Torax Medical offers treatment for gastro esophageal reflux disease that can turn …
  • PolyNovo Ltd (PNV):企業の財務・戦略的SWOT分析
    Summary PolyNovo Ltd (PolyNovo), formerly Calzada Ltd, is a medical device company that develops, manufactures and commercializes biodegradable polymers for use in medical devices. The company provides products such as biodegradable temporizing matrix and negative pressure wound therapy dressing sys …
  • VisionQuest Biomedical LLC:製品パイプライン分析
    Summary VisionQuest Biomedical LLC (VisionQuest) is a medical device company that develops medical imaging tools for the diagnostic services. The company’s products include eyestar, DR-RACS, and neurotherm. Its eyestar product is a total eye disease screening program package; DR-RACS is an automated …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆